CO
₹1,227.90
+62.90(+5.40%)
CONCORDBIO₹1,227.90+5.40%
Value & Investment Index
VIIVII Detail
90 days · zone the stock traded inMultiples vs Peers
Quality Scores
Versus Its Own History
P/E · P/B percentile bandsScenario analysis
stated assumptions, shown workingsCONCORDBIO valuation summary
Concord Biotech Limited trades at 49.8 times trailing earnings. Return on equity is 12.6% and return on capital employed is 17.4%. The dividend yield is 0.56%.
| P/E | 49.8 |
|---|---|
| ROE | 12.6% |
| ROCE | 17.4% |
| Dividend yield | 0.56% |